Mersana Therapeutics reports positive cancer drug results – causing uncontrolled buying.

A cure for cancer is the most desirable statement for scientists and investors alike. However, optimism is often met with disappointment as the task of curing cancer is no easy feat. Despite the difficulty, the scientific world continues to develop drug after drug in an attempt to eradicate the horrific group of diseases. Despite a […]

Novavax’s COVID-19 vaccine enters Phase 1 trials – is Moderna in trouble?

A vaccine is an unlikely solution. However, biotechs often tirelessly work on vaccines even after the expiration date of a virus. For example, vaccines for ebola, Zika, and Sars2 are still in development. Thus if a vaccine is unattainable before COVID-19 fizzles out, biotechs will continue to create a vaccine. Because we do not want […]

Evofem skyrockets after the FDA approves its birth control gel.

Why did the stock rise? Evofem made headlines after the FDA approved Evofem’s (NASDAQ: EVFM) new birth control gel “Phexxi.” Phexxi is an applicator that women insert before sex to prevent pregnancy. The FDA approved the drug through Phase 3 clinical trial, enrolling tests of 1,330 women. Evofem achieved an efficacy rate of 86.3%, which […]

IBM announces company-wide layoffs – are they still worth the investment?

The technology sector continues to take a pounding from the Coronavirus. The demand for enterprise IT products is in free fall. Look no further than the International Business Machines Corporation (NYSE: IBM). Today we will discuss why IBM made headlines this week and discuss whether it is worth the investment at its current trading price. […]

Potential FDA approval sees Seneca surge 100+%

Seneca Biopharma (NASDAQ: SNCA) came out of the markets storming 100% higher today at $1.67. The volcanic surge is off the back on no news, leaving investors confused. SNCA forums on Yahoo Finance and Stockwits are flooded with the same question “why is SNCA up”? Why is Seneca surging? The unsureness of why SNCA is […]

Nano Dimension surges 400% off 3D printing breakthrough.

3D printing is tomorrow’s technological future. The technology is new and creates an itch in the minds of investors, consumers, and the government. The new wave of 3D printers can fabricate anything from keyboards to human body parts. It seems the possible creations are limitless. Making it fair to say that 3D printing is and […]

Novavax look to repeat last week’s 120% gain.

Novavax (NASDAQ:NVAX) look to surge come market open with pre-market up 13% (at the time of writing). Novavax captured the wallets of investors last week when they received $384 million in vaccine funding from CEPI. This week NVAX is expected to captivate investors with a new all-time-high. Which seems achievable, especially if last week’s insane […]

Moderna set to surge after producing positive trial results for COVID-19 vaccine

Moderna announced this morning that their interim Phase 1 data for COVID-19 vaccine has shown positive results. The company has been heavily watched by investors and speculators alike – as their vaccine (mRNA-1273) continues to show positive signs. The announcement confirmed the Biomedical Advanced Research and Development Authority (BARDA) are in support of the companies phase […]

BREAKING: SRNE’s COVID-19 treatment offers 100% protection – is now the time to invest?

It seems most biotechs are reenacting the boy who cried wolf. Especially, as every week a new biotech enters the headlines for COVID-19 vaccine developments. In all honesty a single viable vaccine, let alone multiple, is unlikely. Testing and treatments is where is the consistent share price growth resides. Thus, when a COVID-19 treatment posts […]

Mesoblast set to surge off COVID-19 stem cell trials.

The world is in dire need of a COVID-19 treatment. A vaccine is the plan b for the long-term. However, governments can take action immediately through COVID-19 treatments and testing. Mesoblast (NASDAQ:MESO) and (ASX:MSB), an Australian biotech is developing a stem cell treatment (Remestemcel-L), for COVID-19. The primary reason people die from COVID-19 is due […]

Aurora explodes by 32% – is now the time for cannabis investors?

The Coronavirus pandemic has left the healthcare industry caught up in the middle of a frenzy. The biotech race is heating up. Unsurprisingly, biopharmaceutical companies have seen colossal investor backing over the past few weeks. However, what you may not know is that the cannabis industry is suffering. Since the beginning of the year, the […]

CODX up 2000% and looking to pioneer COVID-19 testing.

The biotech world is in a frenzy. Testing kit and vaccine companies are experiencing extreme investor backing. Despite occasional pump and dumps, the explosive share price growth for biotechs is continuing. However, a vaccine is not the answer because time is not on our side. Also, if you look at Ebola, Zika, and Sars2, a […]

Novavax look to be the COVID-19 vaccine winner after surging 120%.

Novavax (NASDAQ:NVAX) is set to surge come market open with pre-market up 13% (at the time of writing). Novavax captured the wallets of investors last week when they received $384 million in vaccine funding from CEPI. This week NVAX is expected to captivate investors with a new all time-high. Which seems achievable especially if last […]

Quidel stock to pounce after FDA approves rapid antigen COVID-19 test?

The Food and Drug Administration approved the emergency use of Quidel Corporations (NASDAQ:QDEL) rapid antigen testing for use across the country. In recent weeks, antigen testing for COVID-19 has sparked speculation amongst investors – being marked as one of the biggest opportunities in our current market. This year alone has seen Quidel stock reach all […]

Moderna (MRNA) set to cure COVID-19 – is now the time to invest?

MRNA’s key COVID-19 developments so far US government is willing to fund mRNA-173 through every trial until regulatory approval. Biomedical Advanced Research and Development Authority (BARDA) is ready to give Moderna (NASDAQ: MRNA) $483 million to expedite mRNA-173 through clinical development. Lonza Group, via its agreement with Moderna, is manufacturing mRNA-173 at their US and […]

Is BBUS the best way to make money during the crash?

Every investor must understand bulls and bears make money, but pigs get slaughtered. In other words, you can profit when the market goes up or down, but if you are too greedy, you will get burned. We are in a down market (opinion, not advice). Yes, there are bullish recoveries. However, these are known as […]

Wayfair is surging like a rocket – positive earnings could launch W into the stratosphere.

Wayfair (NYSE: W), the gigantic e-commerce store that sells a zillion amount of furniture and home goods, is rocking the investment world. Flashback three weeks ago and COVID-19 pulled Wayfair down to the $25 mark. Let me stress the significance of this bearish decline, $25 equated to a 5 year low. Investors saw the opportunity […]

Why Activision is one of the hottest US stocks right now

Activision Blizzard (NASDA:ATVI) is a well-known video game holding company based in California. You may know them from their infamous franchises of Call of Duty and Overwatch. Like Netflix and Roku, Activision has seen a huge surge in sales as more people are forced in doors. The stock itself has remained somewhat strong as investors prepare […]

Carnival Cruises and Royal Caribbean could go bankrupt – is there any hope?

Carnival Cruise (NYSE: CCL) and Royal Caribbean (NYSE: RCL) experienced extreme turbulence over the past few months. Especially, as the short term future of international travel dims. It seems the cruise line industry, as mentioned by Buffet, will never be the same again. Since our last article on investing in CCL and RCL, both stock […]

Warren Buffett sells $6 Billion in US airline stocks – what this means for Delta, AAL, LUV and UAL investors?

The Godfather of investing – Warren Buffett announced on Saturday that he had sold $6 Billion in US airline stocks. The news came as Buffett announced to the press that his infamous Berkshire Hathaway fund had decided to cut ties with the US airline industry. Buffett explained that after consideration he had decided buying into […]